New Zealand's Effective Tobacco Harm Reduction Strategy

Dec.05.2022
New Zealand's Effective Tobacco Harm Reduction Strategy
New Zealand's successful THR strategy is leading towards its goal of being smoke-free by 2025, with smoking rates decreasing.

The tobacco harm reduction (THR) strategy in New Zealand is proving to be highly effective, and the country is making strides towards achieving its goal of becoming a smoke-free nation by 2025," said Nancy Loucas, co-founder of Aotearoa Vapers Community Advocacy (AVCA).


Her comments were made after the government released statistical data that showed New Zealand's smoking rate had dropped from 9.4% a year ago to a historic low of 8% of people smoking every day.


The smoking rate in New Zealand is now half of what it was ten years ago. In just the past year, the number of smokers has decreased by 56,000 individuals. Given the additional pressures brought on by the pandemic and the ever-increasing cost of living, this is truly fantastic," said Ms. Loucas.


It is worth noting that Maori people have an overall daily smoking rate as low as 19.9%, which is lower than the 22.3% in 2020/21. Meanwhile, 8.3% of New Zealand adults now vape every day.


The AVCA has commended the government's efforts in making smoking cessation services more accessible and introducing customized services from Maori and Pacific providers to boost profits.


During Covid lockdowns and restrictions, smoking rates have increased in other countries, but New Zealand has once again gone against the trend. This is because our Health Ministry and healthcare providers have adopted a Tobacco Harm Reduction (THR) strategy, which has successfully transformed smokers into using electronic cigarettes as a safe and highly effective tool to quit smoking, according to Ms. Loucas.


The AVCA believes that New Zealand can achieve a smoke-free Aotearoa by 2025, where 5% or less of the population smoke regularly.


Another push for the ten-year national goal will be a smoke-free environment and revised regulations on smoking tobacco products. The Health Special Committee of the Parliament will submit its report before December 1st.


Dr. Ayesha Verrall, Deputy Minister of Health, aims to pass smoke-free legislation by the end of this year. The legislation would decrease the number of retail stores able to sell tobacco, reduce the appeal of cigarettes, and ensure that the next generation will never sell tobacco.


Dr. Verrall has strongly advocated using the THR method to reduce deadly smoking. Recently, she stated, "We need to continue supporting smokers to successfully switch to less harmful products.


New Zealand is showcasing to the world how to achieve a smoke-free culture. These latest statistics further demonstrate that countries employing the THR public health approach are ultimately saving many lives," said Nancy Loucas.


2FIRSTS will continue to follow and report on this topic. Further updates will be available on the '2FIRSTS APP'. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Spain’s Nicotine Pouch Bill Faces Opposition from Five EU Countries, Raising Trade Concerns
Spain’s Nicotine Pouch Bill Faces Opposition from Five EU Countries, Raising Trade Concerns
Spain is planning new legislation to regulate e-cigarettes and other novel tobacco products, including setting a cap on nicotine content in pouches. The proposal has sparked protests from five EU countries, including Italy and Sweden, which argue it violates the EU’s principle of free movement of goods.
May.13 by 2FIRSTS.ai
Philip Morris launches new HNB product "IQOS ILUMA i One".
Philip Morris launches new HNB product "IQOS ILUMA i One".
Philip Morris International introduces new HNB product IQOS ILUMA i One in South Korea for $45.
Jun.12 by 2FIRSTS.ai
S. Korean Court Nears Final Ruling on $35M Claim Against PMI, BAT, KT&G
S. Korean Court Nears Final Ruling on $35M Claim Against PMI, BAT, KT&G
South Korea’s National Health Insurance Service (NHIS) filed a lawsuit seeking about 50 billion won (approximately USD 35 million) in damages against Korea Tobacco & Ginseng (KT&G), Philip Morris International Korea, and British American Tobacco Korea, arguing that these companies should reimburse the treatment costs for patients with smoking-related cancers . Originally lodged in April 2014, the case has spanned 11 years and has now entered the final oral-argument phase at the appellate level.
Apr.23 by 2FIRSTS.ai
Russia Proposes Using Tobacco License Fees to Fund COPD Treatment
Russia Proposes Using Tobacco License Fees to Fund COPD Treatment
Russia’s Democratic Forces have proposed using revenue from retail licenses for nicotine-containing products to fund treatment for chronic obstructive pulmonary disease (COPD).
May.19 by 2FIRSTS.ai
South Korea’s Tobacco HTP Device "Lil Solid" FIIT Series Pods Price Cut Effective from May
South Korea’s Tobacco HTP Device "Lil Solid" FIIT Series Pods Price Cut Effective from May
KT&G (Korea Tobacco & Ginseng) announced that, starting from May 1, it will reduce the price of its "FIIT" series pods for the heated tobacco product "Lil Solid" by 200 KRW (0.14 USD) to expand consumer choices and enhance product satisfaction.
Apr.29 by 2FIRSTS.ai
FDA Embraces AI: Generative System to Be Fully Operational by June's End
FDA Embraces AI: Generative System to Be Fully Operational by June's End
FDA plans to fully integrate a generative AI system across its centers by June 30, 2025. This follows the successful completion of an initial pilot, marking a shift in the agency's approach to regulatory processes. The AI tools are expected to streamline the drug approval process, which typically takes six to ten months, by reducing time spent on repetitive tasks.
May.09 by 2FIRSTS.ai